Related Experiment Video
Updated: Sep 27, 2025

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Sox15 Methylation Inhibits Cell Proliferation Through Wnt Signaling in Hepatocellular Carcinoma
Bajin Wei1,2,3,4, Hao Chen5, Xiaobin Chen5
1Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Abstract:
The expression of the SRY-Box Transcription Factor 15 (Sox15) is reduced by DNA methylation, and its progression is suppressed within numerous tumors. However, its effect on hepatocellular carcinoma (HCC) remains unknown. In the present work, the clinical importance and function of Sox15, as well as the underlying molecular mechanism, were explored within HCC. The expression of Sox15 is reduced and positively correlated with prognosis in HCC as analyzed by GEPIA (Gene Expression Profiling Interactive Analysis) and OncoLnc. Meanwhile, the hypermethylated Sox15 promoter CpG-site predicted a dismal HCC prognosis. Besides, ectopic Sox15 expression within the HCC cells (LM3, HUH7, SK-hep-1) remarkably inhibited in vitro cell growth and inhibited xenograft tumorigenesis in the nude mice. Moreover, Sox15 inactivated the Wnt pathway under both in vivo and in vitro conditions. To summarize, Sox15 played a tumor suppressor role within the HCC via the inactivated Wnt pathway. Sox15 and CpG-site methylation of its promoter are the factors that independently predict the prognosis of HCC.
Insights
SRY-Box Transcription Factor 15 (Sox15) acts as a tumor suppressor in hepatocellular carcinoma (HCC). Reduced Sox15 expression and promoter methylation correlate with poor HCC prognosis, potentially via the Wnt pathway.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- SRY-Box Transcription Factor 15 (Sox15) expression is reduced in various tumors due to DNA methylation, but its role in hepatocellular carcinoma (HCC) is unclear.
- Understanding Sox15's function and regulation in HCC is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To investigate the clinical significance and molecular mechanisms of Sox15 in HCC.
- To determine the correlation between Sox15 expression, promoter methylation, and HCC patient prognosis.
Main Methods:
- Analysis of Sox15 expression and prognosis using GEPIA and OncoLnc databases.
- Assessment of Sox15 promoter CpG-site methylation in relation to HCC prognosis.
- In vitro studies involving ectopic Sox15 expression in HCC cell lines (LM3, HUH7, SK-hep-1).
- In vivo xenograft tumor models in nude mice to evaluate Sox15's effect on tumorigenesis.
- Investigation of Sox15's impact on the Wnt signaling pathway.
Main Results:
- Sox15 expression is reduced in HCC and positively correlates with improved patient prognosis.
- Hypermethylation of the Sox15 promoter CpG site is associated with a poorer HCC prognosis.
- Ectopic Sox15 expression significantly inhibited HCC cell growth in vitro and suppressed tumor formation in vivo.
- Sox15 was found to inactivate the Wnt signaling pathway in both in vitro and in vivo HCC models.
Conclusions:
- Sox15 functions as a tumor suppressor in HCC by inactivating the Wnt pathway.
- Both Sox15 expression levels and its promoter's CpG-site methylation are independent prognostic factors for HCC.
Related Concept Videos
Pleiotropy
Canonical Wnt Signaling Pathway
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
Non-Canonical Wnt Signaling Pathways
Cell Specific Gene Expression

